New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore

AI Briefing

• – ZEPZELCA and atezolizumab approved for ES-SCLC in Australia and Singapore
• – First-line maintenance treatment for extensive-stage small cell lung cancer
• – New combination therapy offers hope for patients with aggressive lung cancer